| Summary of shareholders' equity activity |
The following tables summarize our shareholders’ equity activity for the three months ended March 31, 2026 and March 31, 2025, respectively: | | | | | | | | | | Paid-in Capital in Excess of Par Value | | | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interest in Consolidated Subsidiaries | | Balance at December 31, 2025 | | | | | | | | Comprehensive income (loss): | | | | | | | | | | | | | | | | Other comprehensive income (loss) | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at March 31, 2026 | | | | | | | |
| | | In the first quarter of 2026, we issued common stock from treasury shares for stock options exercised, restricted stock grants, performance shares under our performance unit program, and purchases under our employee stock purchase plan. |
| | | | | | | | | | Paid-in Capital in Excess of Par Value | | | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interest in Consolidated Subsidiaries | | Balance at December 31, 2024 | | | | | | | | Comprehensive income (loss): | | | | | | | | | | | | | | | | Other comprehensive income (loss) | | | | | | | | Cash dividends ($0.17 per share) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance at March 31, 2025 | | | | | | | |
| | | In the first quarter of 2025, we issued common stock from treasury shares for stock options exercised, restricted stock grants, performance shares under our performance unit program, and purchases under our employee stock purchase plan. |
|